HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jørgen Jeppesen Selected Research

Marfan Syndrome (Marfan's Syndrome)

10/2012Fibrillin-1 genotype and risk of prevalent hypertension: a study in two independent populations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jørgen Jeppesen Research Topics

Disease

13Hypertension (High Blood Pressure)
01/2017 - 05/2007
12Cardiovascular Diseases (Cardiovascular Disease)
09/2013 - 01/2003
5Stroke (Strokes)
03/2015 - 06/2009
4Myocardial Ischemia (Ischemic Heart Diseases)
03/2015 - 01/2003
4Inflammation (Inflammations)
08/2013 - 10/2008
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2016 - 03/2003
3Atherosclerotic Plaque (Atheroma)
03/2012 - 06/2009
2Glaucoma
01/2017 - 03/2014
2Diabetes Mellitus
01/2013 - 02/2006
2Myocardial Infarction
12/2009 - 06/2009
1Pulmonary Edema
01/2022
1Heart Failure
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019
1Obesity
12/2016
1Type 2 Diabetes Mellitus (MODY)
03/2015
1Hypersensitivity (Allergy)
03/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2015
1Atherosclerosis
08/2013
1Masked Hypertension
05/2013
1Marfan Syndrome (Marfan's Syndrome)
10/2012
1White Coat Hypertension
03/2012
1Neoplasms (Cancer)
04/2011
1Hypercholesterolemia
08/2010
1Hyperinsulinism (Hyperinsulinemia)
08/2010
1Overweight
03/2010
1Tonsillitis
01/2009
1Infections
01/2009
1Disseminated Intravascular Coagulation
01/2009
1Septic Shock (Toxic Shock Syndrome)
01/2009
1Insulin Resistance
10/2008
1Dyslipidemias (Dyslipidemia)
03/2003
1Hypertriglyceridemia
03/2003

Drug/Important Bio-Agent (IBA)

12Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 05/2007
5C-Reactive ProteinIBA
09/2013 - 10/2008
5LipidsIBA
04/2010 - 03/2003
4Biomarkers (Surrogate Marker)IBA
03/2015 - 04/2011
4CreatinineIBA
08/2013 - 06/2009
4AlbuminsIBA
08/2013 - 06/2009
4Triglycerides (Triacylglycerol)IBA
08/2010 - 01/2003
4HDL CholesterolIBA
03/2010 - 01/2003
3Urokinase Plasminogen Activator ReceptorsIBA
01/2019 - 04/2011
3CholesterolIBA
05/2014 - 02/2006
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2016 - 08/2010
2AdiponectinIBA
03/2015 - 03/2010
2LeptinIBA
10/2010 - 03/2010
2Fibrinogen (Factor I)FDA Link
03/2010 - 04/2009
2Hypoglycemic Agents (Hypoglycemics)IBA
12/2009 - 06/2009
2LDL CholesterolIBA
12/2006 - 03/2003
1DNA (Deoxyribonucleic Acid)IBA
12/2016
18-Hydroxy-2'-DeoxyguanosineIBA
12/2016
1RNA (Ribonucleic Acid)IBA
12/2016
18-hydroxyguanosineIBA
12/2016
1Immunoglobulin E (IgE)IBA
03/2015
1Complement System Proteins (Complement)IBA
02/2015
1SphingolipidsIBA
01/2015
1Fibrillin-1IBA
10/2012
1SphingosineIBA
05/2011
1Phosphates (Orthophosphate)IBA
05/2011
1CeramidesIBA
05/2011
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2010
1Insulin (Novolin)FDA Link
08/2010
1Hormones (Hormone)IBA
03/2010
1Glucose (Dextrose)FDA LinkGeneric
03/2010
1Penicillins (Penicillin)FDA Link
01/2009
1Dacarbazine (DIC)FDA LinkGeneric
01/2009
1Clindamycin (Cleocin)FDA LinkGeneric
01/2009
1Cefuroxime (Zinacef)FDA LinkGeneric
01/2009
1Lipoproteins (Lipoprotein)IBA
03/2003

Therapy/Procedure

3Therapeutics
03/2014 - 03/2012